Learning Path

Access and Inclusion in Psychedelic Treatment

This webinar series explores topics about the present challenges and future opportunities for addressing social injustice in the field of psychedelic medicine; focusing on the role of the clinician’s voice in context of the larger healthcare system.

Here's what you'll learn:

Critique the implications of drug policy that impact marginalized populations’ access to psychedelic-assisted therapy.

Describe the mental health and policy barriers that perpetuate stigma and inequitable access to psychedelic-assisted therapy.

Explain the ways in which bias against individuals with mental illness are used to invalidate their perspectives, and how this relates to psychedelic-assisted therapy.

Analyze the role of ethnic and racial identity in psychedelic-assisted therapy research.

Analyze Intersection between research, policy, corporatization of psychedelics and its impact.

Describe current psychedelic decriminalization efforts in the US and their relationship to existing drug and religious use policies as well as its impact on indigenous communities.

Describe the role of gender within psychedelic therapist dyads, and between dyads and participants.

Demonstrate knowledge of unique aspects of PTSD in military populations that may impact their treatment with psychedelic-assisted therapy.

Explain the role and application of leading ethical guidelines for psychedelic-assisted therapy.

Demonstrate knowledge of controversies related to therapist training, as well as therapist self-disclosure of personal experience with psychedelics.

Start Learning Path Buy $100.00

Enroll in this learning track and beging your journey to improving your skills in access and inclusion.

1.5hr

Access & Inclusion in Psychedelic Treatment | Week 1 On Demand

Rights, Regulations, and Reconciliation: Exploring an Equitable Drug Policy

1hr

Access & Inclusion in Psychedelic Treatment | Week 2 On Demand

Challenges of Mainstreaming Psychedelic-assisted Therapies: A Critical Analysis of the Mental Health Model

1hr

Access & Inclusion in Psychedelic Treatment | Week 3 On Demand

Cultural Elevation of Sanity and Abstinence and Implications for Psychedelic Assisted Therapy

1hr

Access & Inclusion in Psychedelic Treatment | Week 4 On Demand

Inclusion in Psychedelic-assisted therapy: Racial disparities in research, Racial Trauma, Race as Part of Set and Setting

1hr

Access & Inclusion in Psychedelic Treatment | Week 5 On Demand

Challenges to Challenging the Status Quo in Psychedelic Research and Treatment

1hr

Access & Inclusion in Psychedelic Treatment | Week 6 On Demand

Whose Medicine Is It? Decriminalization, medicalization and infringement on indigenous communities

1hr

Access & Inclusion in Psychedelic Treatment | Week 7 On Demand

Inclusive Models of Sexuality and Gender in Psychedelic Assisted Psychotherapy

1hr

Access & Inclusion in Psychedelic Treatment | Week 8 On Demand

Cultural Attitudes and PTSD: Who Gets Compassionate Care?

1hr

Access & Inclusion in Psychedelic Treatment | Week 9 On Demand

Ethical Considerations and Guidelines for Community Practice